Leukemia, Lymphoid: Clinical Trials

4 trials for Leukemia, Lymphoid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 enrolling by invitation. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Enrolling by invitation 4

Follow Leukemia, Lymphoid: new trials by email Literature Review of Leukemia, Lymphoid trials Research Report on Leukemia, Lymphoid

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
Induction Phase, Re-Induction Phase, Post-Remission - Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia, CD19+ Acute Leukemia
Phase 2Enrolling by invitationSWOG Cancer Research Network552026-04-132026-10-05
HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).
HVA - Newly Diagnosed Mixed Phenotype Acute Leukemia (MPAL)
Phase 2Enrolling by invitationGuangdong Second Provincial General Hospital402026-04-012026-04-08
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia
Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium bifidum - Probiotics, Gastrointestinal Diseases
Phase 2Enrolling by invitationNational Institute of Pediatrics, Mexico1202025-02-012025-03-14
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
CliniMacs TCR alpha-beta-Biotin system - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2Enrolling by invitationMichael Pulsipher502015-10-012025-05-04

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Gastrointestinal Diseases (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Leukemia (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Bone Marrow Diseases (1)  ·  Digestive System Diseases (1)  ·  Leukemia, Myeloid (1)

Interventions

Maintenance (1)

Sponsors

Guangdong Second Provincial General Hospital (1)  ·  Michael Pulsipher (1)  ·  National Institute of Pediatrics, Mexico (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (2)  ·  China (1)  ·  Mexico (1)

Top investigators

Anjali S Advani (1)  ·  Michael Pulsipher, MD (1)  ·  Sara Espinosa-Padilla, Ph.D. (1)

Results publications

PMID 11408503, PMID 11972517, PMID 14966830, PMID 15253677, PMID 17516870, PMID 17576459, PMID 19553647, PMID 21879172, PMID 23727426, PMID 23757085, PMID 24290319, PMID 24428625, PMID 24618152, PMID 24713845, PMID 25040088, PMID 25304690, PMID 25651996, PMID 26888258, PMID 28270698, PMID 28287336, PMID 28413626, PMID 28426102, PMID 28646338, PMID 29182564, PMID 29518185, PMID 30168576, PMID 31033786, PMID 31280227, PMID 31777071, PMID 31826366, PMID 35776909, PMID 39042892, PMID 9718381